309 related articles for article (PubMed ID: 24483936)
1. Toward a rationale for the PTC124 (Ataluren) promoted readthrough of premature stop codons: a computational approach and GFP-reporter cell-based assay.
Lentini L; Melfi R; Di Leonardo A; Spinello A; Barone G; Pace A; Palumbo Piccionello A; Pibiri I
Mol Pharm; 2014 Mar; 11(3):653-64. PubMed ID: 24483936
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of premature stop codon readthrough in the CFTR gene by Ataluren (PTC124) derivatives.
Pibiri I; Lentini L; Melfi R; Gallucci G; Pace A; Spinello A; Barone G; Di Leonardo A
Eur J Med Chem; 2015 Aug; 101():236-44. PubMed ID: 26142488
[TBL] [Abstract][Full Text] [Related]
3. Exploring the readthrough of nonsense mutations by non-acidic Ataluren analogues selected by ligand-based virtual screening.
Pibiri I; Lentini L; Tutone M; Melfi R; Pace A; Di Leonardo A
Eur J Med Chem; 2016 Oct; 122():429-435. PubMed ID: 27404557
[TBL] [Abstract][Full Text] [Related]
4. Rescuing the CFTR protein function: Introducing 1,3,4-oxadiazoles as translational readthrough inducing drugs.
Pibiri I; Lentini L; Melfi R; Tutone M; Baldassano S; Ricco Galluzzo P; Di Leonardo A; Pace A
Eur J Med Chem; 2018 Nov; 159():126-142. PubMed ID: 30278331
[TBL] [Abstract][Full Text] [Related]
5. Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis.
Sermet-Gaudelus I; Boeck KD; Casimir GJ; Vermeulen F; Leal T; Mogenet A; Roussel D; Fritsch J; Hanssens L; Hirawat S; Miller NL; Constantine S; Reha A; Ajayi T; Elfring GL; Miller LL
Am J Respir Crit Care Med; 2010 Nov; 182(10):1262-72. PubMed ID: 20622033
[TBL] [Abstract][Full Text] [Related]
6. Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.
Wilschanski M; Miller LL; Shoseyov D; Blau H; Rivlin J; Aviram M; Cohen M; Armoni S; Yaakov Y; Pugatsch T; Cohen-Cymberknoh M; Miller NL; Reha A; Northcutt VJ; Hirawat S; Donnelly K; Elfring GL; Ajayi T; Kerem E
Eur Respir J; 2011 Jul; 38(1):59-69. PubMed ID: 21233271
[TBL] [Abstract][Full Text] [Related]
7. PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model.
Du M; Liu X; Welch EM; Hirawat S; Peltz SW; Bedwell DM
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):2064-9. PubMed ID: 18272502
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.
Kerem E; Hirawat S; Armoni S; Yaakov Y; Shoseyov D; Cohen M; Nissim-Rafinia M; Blau H; Rivlin J; Aviram M; Elfring GL; Northcutt VJ; Miller LL; Kerem B; Wilschanski M
Lancet; 2008 Aug; 372(9640):719-27. PubMed ID: 18722008
[TBL] [Abstract][Full Text] [Related]
9. Investigating REPAIRv2 as a Tool to Edit
Melfi R; Cancemi P; Chiavetta R; Barra V; Lentini L; Di Leonardo A
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640650
[TBL] [Abstract][Full Text] [Related]
10. Targeting Nonsense: Optimization of 1,2,4-Oxadiazole TRIDs to Rescue CFTR Expression and Functionality in Cystic Fibrosis Cell Model Systems.
Pibiri I; Melfi R; Tutone M; Di Leonardo A; Pace A; Lentini L
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899265
[TBL] [Abstract][Full Text] [Related]
11. Serum starvation enhances nonsense mutation readthrough.
Wittenstein A; Caspi M; David Y; Shorer Y; Nadar-Ponniah PT; Rosin-Arbesfeld R
J Mol Med (Berl); 2019 Dec; 97(12):1695-1710. PubMed ID: 31786671
[TBL] [Abstract][Full Text] [Related]
12. Use of 2,6-diaminopurine as a potent suppressor of UGA premature stop codons in cystic fibrosis.
Leroy C; Spelier S; Essonghe NC; Poix V; Kong R; Gizzi P; Bourban C; Amand S; Bailly C; Guilbert R; Hannebique D; Persoons P; Arhant G; Prévotat A; Reix P; Hubert D; Gérardin M; Chamaillard M; Prevarskaya N; Rebuffat S; Shapovalov G; Beekman J; Lejeune F
Mol Ther; 2023 Apr; 31(4):970-985. PubMed ID: 36641622
[TBL] [Abstract][Full Text] [Related]
13. Nonsense-mediated mRNA decay and cystic fibrosis.
Linde L; Kerem B
Methods Mol Biol; 2011; 741():137-54. PubMed ID: 21594783
[TBL] [Abstract][Full Text] [Related]
14. Caffeine boosts Ataluren's readthrough activity.
Lentini L; Melfi R; Cancemi P; Pibiri I; Di Leonardo A
Heliyon; 2019 Jun; 5(6):e01963. PubMed ID: 31294114
[TBL] [Abstract][Full Text] [Related]
15. Ataluren and aminoglycosides stimulate read-through of nonsense codons by orthogonal mechanisms.
Ng MY; Li H; Ghelfi MD; Goldman YE; Cooperman BS
Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33414181
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations.
Mutyam V; Du M; Xue X; Keeling KM; White EL; Bostwick JR; Rasmussen L; Liu B; Mazur M; Hong JS; Falk Libby E; Liang F; Shang H; Mense M; Suto MJ; Bedwell DM; Rowe SM
Am J Respir Crit Care Med; 2016 Nov; 194(9):1092-1103. PubMed ID: 27104944
[TBL] [Abstract][Full Text] [Related]
17. Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy.
Howard MT; Shirts BH; Petros LM; Flanigan KM; Gesteland RF; Atkins JF
Ann Neurol; 2000 Aug; 48(2):164-9. PubMed ID: 10939566
[TBL] [Abstract][Full Text] [Related]
18. Effect of Ataluren on dystrophin mutations.
Berger J; Li M; Berger S; Meilak M; Rientjes J; Currie PD
J Cell Mol Med; 2020 Jun; 24(12):6680-6689. PubMed ID: 32343037
[TBL] [Abstract][Full Text] [Related]
19. A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays.
McElroy SP; Nomura T; Torrie LS; Warbrick E; Gartner U; Wood G; McLean WH
PLoS Biol; 2013; 11(6):e1001593. PubMed ID: 23824517
[TBL] [Abstract][Full Text] [Related]
20. Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs).
Campofelice A; Lentini L; Di Leonardo A; Melfi R; Tutone M; Pace A; Pibiri I
Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31284579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
